NAT10 promotes solute carrier family 7 member 11 (SLC7 A11) expression through ac4C acetylation, which inhibits sorafenib-induced ferroptosis in nasopharyngeal carcinoma cells. Here, NAT10 is linked to nasopharyngeal carcinoma.